INCOME STATEMENT

(Unit: KRW Billion)
Income Statement (2020 ~ 2025)
2020 2021 2022 2023 2024 2025
Revenue 1,165 1,568 2,437 2,939 3,497 4,557
Operating Profit 293 537 969 1,206 1,321 2,069
(Unit: KRW Billion)

* Consolidated financial information is prepared in accordance with K-IFRS

* The 2022 revenue and operating profit are consolidated figures including the U.S. subsidiary and have not been audited by an external auditor.

BALANCE SHEET

(Unit: KRW Billion)
BALANCE SHEET (2018 ~ 2024)
2020 2021 2022 2023 2024 2025
Total Assets 6,424 7,970 14,309 13,996 15,445 11,061
Total Liabilities 1,825 2,979 5,360 4,109 4,511 3,610
Total Equities 4,599 4,991 8,949 9,887 10,935 7,451
(Unit : KRW Billion)

* Consolidated financial information is prepared in accordance with K-IFRS

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required